Sanford Canton Inwood Medical Center
440 N Hiawatha Dr, Canton, SD · Sanford Health · · NPI 1740244540
Published prices by procedure
Cash price is what you pay without insurance. The negotiated range spans the lowest to highest rate this hospital agreed with insurers.
| Procedure | Cash price | Gross charge | Negotiated range | Payers |
|---|---|---|---|---|
| Infect ag na hpv high-risk types CPT 87624 | $124.80 | $156.00 | $53.35 – $140.40 | 14 |
| Infect ag na influenza r/amp 1st 2 types CPT 87502 | $248.80 | $311.00 | $106.36 – $279.90 | 14 |
| Infect ag na orthopoxvirus amp prb each CPT 87593 | $144.00 | $180.00 | $61.56 – $162.00 | 14 |
| Infectious agent antigen immunoassay ql/sq multi step clostridium difficile toxin CPT 87324 | $81.60 | $102.00 | $34.88 – $91.80 | 14 |
| Infectious agent antigen immunoassay ql/sq multi step cryptosporidium CPT 87328 | $88.80 | $111.00 | $24.97 – $65.70 | 14 |
| Infectious agent antigen immunoassay ql/sq multi step giardia CPT 87329 | $72.00 | $90.00 | $28.73 – $75.60 | 14 |
| Infectious agent antigen immunoassay ql/sq multi step helicobacter pylori stool CPT 87338 | $127.20 | $159.00 | $54.38 – $143.10 | 14 |
| Infectious agent antigen immunoassay ql/sq multi step hepatitis b surface agn CPT 87340 | $46.40 | $58.00 | $19.84 – $52.20 | 14 |
| Infectious agent antigen immunoassay ql/sq multi step hiv-1 antigen(s) hiv-1&2 antibodies CPT 87389 | $70.40 | $88.00 | $30.10 – $79.20 | 14 |
| Infectious agent antigen immunoassay ql/sq multi step legionella urine CPT 87449 | $164.00 | $205.00 | $13.34 – $35.10 | 14 |
| Infectious agent antigen immunoassay ql/sq multi step rotavirus CPT 87425 | $77.60 | $97.00 | $33.17 – $87.30 | 14 |
| Infectious agent antigen immunoassay ql/sq multi step shiga-like toxin CPT 87427 | $67.20 | $84.00 | $28.73 – $75.60 | 14 |
| Infectious agent nucleic acid amplified probe CPT 87798 | $127.20 | $159.00 | $36.94 – $97.20 | 14 |
| Infectious agent nucleic acid amplified probe chlamydia trachomatis CPT 87491 | $181.60 | $227.00 | $48.91 – $128.70 | 14 |
| Infectious agent nucleic acid amplified probe clostridium difficile toxin gene(s) CPT 87493 | $130.40 | $163.00 | $55.75 – $146.70 | 14 |
| Infectious agent nucleic acid amplified probe hsv-1 CPT 87529 | $160.00 | $200.00 | $68.40 – $180.00 | 14 |
| Infectious agent nucleic acid amplified probe methicillin resistant staphylococcus aureus CPT 87641 | $107.20 | $134.00 | $45.83 – $120.60 | 14 |
| Infectious agent nucleic acid amplified probe mycobacteria tuberculosis CPT 87556 | $170.40 | $213.00 | $72.85 – $191.70 | 14 |
| Infectious agent nucleic acid amplified probe neisseria gonorrhoeae CPT 87591 | $128.80 | $161.00 | $36.94 – $97.20 | 14 |
| Infectious agent nucleic acid amplified probe sars-cov-2/covid-19 CPT 87635 | $124.80 | $156.00 | $53.35 – $140.40 | 14 |
| Infectious agent nucleic acid amplified probe sars-cov-2/inf a & b CPT 87636 | $349.60 | $437.00 | $149.45 – $393.30 | 14 |
| Infectious agent nucleic acid amplified probe sars-cov-2/inf a&b/rsv CPT 87637 | $460.80 | $576.00 | $196.99 – $518.40 | 14 |
| Infectious agent nucleic acid amplified probe streptococcus group a CPT 87651 | $105.60 | $132.00 | $45.14 – $118.80 | 14 |
| Infectious agent nucleic acid amplified probe trichomonas vaginalis CPT 87661 | $105.60 | $132.00 | $45.14 – $118.80 | 14 |
| Infectious agent nucleic acid amp probe multiplex chlamydia trachomatis neisseria gonorrhoeae CPT 87494 | $310.40 | $388.00 | $85.84 – $225.90 | 14 |
| Infectious agent nucleic acid multiplex amplified probe gi pathogen 12-25 targets CPT 87507 | $1,227.20 | $1,534.00 | $524.63 – $1,380.60 | 14 |
| Infectious agent nucleic acid multiplex amplified probe gi pathogen 3-5 targets CPT 87505 | $312.80 | $391.00 | $133.72 – $351.90 | 14 |
| Infectious agent nucleic acid multiplex amplified probe gi pathogen 6-11 targets CPT 87506 | $757.60 | $947.00 | $323.87 – $852.30 | 14 |
| Infectious agent nucleic acid quantification bk virus CPT 87799 | $179.20 | $224.00 | $44.12 – $116.10 | 14 |
| Infectious agent nucleic acid quantification hepatitis b CPT 87517 | $100.00 | $125.00 | $42.75 – $112.50 | 14 |
| Infectious agent nucleic acid quantification hepatitis c CPT 87522 | $293.60 | $367.00 | $51.30 – $135.00 | 14 |
| Infectious agent nucleic acid quantification hiv-1 CPT 87536 | $413.60 | $517.00 | $176.81 – $465.30 | 14 |
| Infectious agent nucleic acid respiratory virus multiplex amplified probe 3-5 targets CPT 87631 | $348.00 | $435.00 | $148.77 – $391.50 | 14 |
| Infliximab 100 mg intravenous solution HCPCS J1745 | not published | not published | $32.81 – $32.81 | 1 |
| Infliximab-axxq 100 mg intravenous solution HCPCS Q5121 | not published | not published | $21.68 – $21.68 | 1 |
| Infliximab-dyyb 100 mg intravenous solution HCPCS Q5103 | $791.51 | $989.38 | $13.88 – $890.44 | 14 |
| Inj acetaminophen -fresenius HCPCS J0134 | $100.72 | $125.90 | $43.06 – $113.31 | 14 |
| Inj, adzynma, 10 iu HCPCS J7171 | not published | not published | $35.25 – $35.25 | 1 |
| Inj anifrolumab-fnia 1mg HCPCS J0491 | not published | not published | $17.63 – $17.63 | 1 |
| Inj. asceniv HCPCS J1554 | not published | not published | $500.66 – $500.66 | 1 |
| Inj aval alfa-nqpt 4mg HCPCS J0219 | not published | not published | $79.24 – $79.24 | 1 |
| Inj., benralizumab, 1 mg HCPCS J0517 | $7,828.28 | $9,785.34 | $170.48 – $8,806.81 | 14 |
| Inj, cefepime hcl (b braun) HCPCS J0703 | $129.80 | $162.25 | $54.82 – $144.25 | 14 |
| Inj., cerliponase alfa 1 mg HCPCS J0567 | not published | not published | $116.40 – $116.40 | 1 |
| Inj, cipaglucosidase, 5 mg HCPCS J1203 | not published | not published | $89.74 – $89.74 | 1 |
| Inj cutaquig 100 mg HCPCS J1551 | not published | not published | $14.78 – $14.78 | 1 |
| Inj cuvitru, 100 mg HCPCS J1555 | not published | not published | $17.14 – $17.14 | 1 |
| Inj, daptomycin (hospira) HCPCS J0877 | $85.70 | $107.12 | $36.64 – $96.41 | 14 |
| Inj, donanemab-azbt, 2 mg HCPCS J0175 | not published | not published | $4.16 – $4.16 | 1 |
| Injection, burosumab-twza 1m HCPCS J0584 | not published | not published | $478.43 – $478.43 | 1 |
| Injection, casimersen, 10 mg HCPCS J1426 | not published | not published | $160.00 – $160.00 | 1 |
| Injection, daratumumab 10 mg HCPCS J9145 | not published | not published | $78.01 – $78.01 | 1 |
| Injection, edaravone, 1 mg HCPCS J1301 | not published | not published | $22.58 – $22.58 | 1 |
| Injection, fulvestrant HCPCS J9395 | $467.77 | $584.71 | $199.97 – $526.24 | 14 |
| Injection, inclisiran, 1 mg HCPCS J1306 | $5,260.16 | $6,575.19 | $2,248.71 – $5,917.67 | 14 |
| Injection, renflexis HCPCS Q5104 | $689.86 | $862.32 | $27.68 – $743.18 | 14 |
| Injection, ruconest HCPCS J0596 | not published | not published | $35.36 – $35.36 | 1 |
| Injection(s) anesthetic agent(s) and/or steroid other peripheral nerve/branch (both sides) CPT 64450 | $1,136.00 | $1,420.00 | $485.64 – $1,278.00 | 14 |
| Injection(s) trigger point(s) single/multiple 1 or 2 muscle(s) CPT 20552 | $613.60 | $767.00 | $262.31 – $690.30 | 14 |
| Injection therapeutic/prophylactic/diagnostic each addl sequential IV push same substance/drug CPT 96376 | $165.60 | $207.00 | $33.60 – $175.50 | 14 |
| Inj efgart-alfa 2mg hya-qvfc HCPCS J9334 | not published | not published | $33.75 – $33.75 | 1 |
| Inj eflapegrastim-xnst 0.1mg HCPCS J1449 | not published | not published | $23.18 – $23.18 | 1 |
| Inj, eteplirsen, 10 mg HCPCS J1428 | not published | not published | $160.00 – $160.00 | 1 |
| Inj, evinacumab-dgnb, 5mg HCPCS J1305 | not published | not published | $189.83 – $189.83 | 1 |
| Inj. fe derisomaltose 10 mg HCPCS J1437 | $3,179.68 | $3,974.60 | $1,359.31 – $3,577.14 | 14 |
| Inj givosiran 0.5 mg HCPCS J0223 | not published | not published | $114.26 – $114.26 | 1 |
| Inj golodirsen 10 mg HCPCS J1429 | not published | not published | $160.00 – $160.00 | 1 |
| Inj., haegarda 10 units HCPCS J0599 | not published | not published | $14.43 – $14.43 | 1 |
| Inj. herceptin hylecta, 10mg HCPCS J9356 | not published | not published | $76.42 – $76.42 | 1 |
| Inj herzuma 10 mg HCPCS Q5113 | not published | not published | $72.41 – $72.41 | 1 |
| Inj hydroxocobalamin IV 25mg HCPCS J3424 | $1,498.47 | $1,873.08 | $640.59 – $1,685.77 | 14 |
| Inj., ibalizumab-uiyk, 10 mg HCPCS J1746 | not published | not published | $78.53 – $78.53 | 1 |
| Inj, imm glob bivigam, 500mg HCPCS J1556 | not published | not published | $76.58 – $76.58 | 1 |
| Inj. inebilizumab-cdon, 1 mg HCPCS J1823 | not published | not published | $493.54 – $493.54 | 1 |
| Inj ivig privigen 500 mg HCPCS J1459 | not published | not published | $49.50 – $49.50 | 1 |
| Inj., lanadelumab-flyo, 1 mg HCPCS J0593 | not published | not published | $89.54 – $89.54 | 1 |
| Inj, lecanemab-irmb, 1 mg HCPCS J0174 | not published | not published | $1.35 – $1.35 | 1 |
| Inj, lidocaine w epinephrine HCPCS J2004 | $13.01 | $16.26 | $5.53 – $14.54 | 14 |
| Inj. lumasiran, 0.5 mg HCPCS J0224 | not published | not published | $323.89 – $323.89 | 1 |
| Inj octafluoropropane mic,ml HCPCS Q9956 | $196.00 | $245.00 | $83.79 – $220.50 | 14 |
| Inj ogivri 10 mg HCPCS Q5114 | not published | not published | $64.87 – $64.87 | 1 |
| Inj olipudase alfa-rpcp 1mg HCPCS J0218 | not published | not published | $389.78 – $389.78 | 1 |
| Inj ontruzant 10 mg HCPCS Q5112 | not published | not published | $40.92 – $40.92 | 1 |
| Inj, panzyga, 500 mg HCPCS J1576 | not published | not published | $68.74 – $68.74 | 1 |
| Inj., patisiran, 0.1 mg HCPCS J0222 | not published | not published | $100.73 – $100.73 | 1 |
| Inj pegfilgrastim-bmez 0.5mg HCPCS Q5120 | not published | not published | $327.13 – $327.13 | 1 |
| Inj pozelimab-bbfg, 1 mg HCPCS J9376 | not published | not published | $90.87 – $90.87 | 1 |
| Inj, releuko 1 mcg HCPCS Q5125 | $393.32 | $491.64 | $168.14 – $442.48 | 14 |
| Inj sebelipase alfa 1 mg HCPCS J2840 | not published | not published | $510.50 – $510.50 | 1 |
| Inj, sutimlimab-jome, 10 mg HCPCS J1302 | not published | not published | $18.49 – $18.49 | 1 |
| Inj, taliglucerace alfa 10 u HCPCS J3060 | not published | not published | $43.39 – $43.39 | 1 |
| Inj. teprotumumab-trbw 10 mg HCPCS J3241 | not published | not published | $350.36 – $350.36 | 1 |
| Inj., tildrakizumab, 1 mg HCPCS J3245 | not published | not published | $138.49 – $138.49 | 1 |
| Inj, tislelizumab-jsgr HCPCS J9329 | not published | not published | $66.09 – $66.09 | 1 |
| Inj, tofidence, 1 mg HCPCS Q5133 | not published | not published | $5.55 – $5.55 | 1 |
| Inj, tyenne, 1 mg HCPCS Q5135 | not published | not published | $5.15 – $5.15 | 1 |
| Inj velmanase alfa-tycv 1 mg HCPCS J0217 | not published | not published | $450.34 – $450.34 | 1 |
| Inj., vestronidase alfa-vjbk HCPCS J3397 | not published | not published | $263.70 – $263.70 | 1 |
| Inj. viltolarsen HCPCS J1427 | not published | not published | $56.40 – $56.40 | 1 |
| Inj. xembify, 100 mg HCPCS J1558 | not published | not published | $14.59 – $14.59 | 1 |
A missing value means the hospital did not publish that price — it never means the price is zero. Real bills can add facility fees, supplies and professional fees; see our methodology.